Investors in the company include business people, physicians and a Silicon Valley firm, according to the report.
FloSpine’s main product focus is KeyLift, a product that relieves compression from spinal stenosis. It is the first expandable interlaminar stabilization procedure for the condition on the market, according to the devicemaker.
FloSpine was founded in 2011 and is headquartered at Florida Atlantic University. It has a team of 12. The company holds eight patents for devices geared toward the spine, including the KeyLift.
The KeyLift was developed alongside Oklahoma City-based surgeon Cheng-Lun Soo, MD, who had been using FloSpine products for several years, according to the report. The device received FDA clearance last fall and already has been used in several procedures.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
